Tag: Merck

Merck closed its $10.8 billion acquisition of Prometheus Biosciences, setting the stage for the drugmaker’s pursuit of an immunology blockbuster. In a news release on...

Merck has filed a lawsuit against the Biden administration regarding Medicare's increased authority to lower drug prices for senior citizens under the Inflation Reduction...

Merck and Glenmark Pharmaceuticals settled claims for $573 million over allegations of delaying a generic version of the cholesterol drug Zetia. Merck reported in its...

On Sunday Merck announced it will buy Prometheus Biosciences for about $10.8 billion, building up its presence in immunology.All the shares of Prometheus Biosciences will be acquired by a...

Two large Pharma companies must face antitrust suit over generic delays. Merck and Glenmark Pharmaceuticals are headed for an antitrust trial over claims they...

Merck has agreed to acquire Imago BioSciences, a California-based biotechnology company focused on bone marrow disorders, for more than $1 billion in cash. The deal announced Monday...

Spain's competition watchdog has slapped a 39 million-euro ($38.45 million) fine on US-based Merck for anti-competitive behaviour in a case brought by Spanish rival Insud...

Merck & Co. already owns a stake in antibody-drug conjugate specialist Seagen. But now, the New Jersey pharma appears to want the whole thing. The...

Merck has received antitrust clearance from the competition authorities in Germany and Austria to tender an offer for the acquisition of clinical-stage biopharmaceutical firm...

Merck’s $11.5 billion Acceleron Pharma buyout may not happen quite as soon as the Kenilworth, NJ-based pharma company had hoped, reported Fierce Pharma. Merck revealed...